Robinson Pharma Inc., Successfully Completes Surveillance Audit Conducted by STR for Retail Qualification Program

Robinson Pharma Inc., (RPI) announced that it successfully completed a surveillance audit for cGMP compliant manufacture of dietary supplements. The audit was performed by STR, a leading global third party testing and auditing firm focused on quality systems and analysis. RPI is committed to continuing its company wide quality initiative. RPI has focused considerable effort on building its manufacturing infrastructure in such a manner as to facilitate a product quality centric approach to all its operations. This initiative is carried out through significant investments in state of the art manufacturing systems that feature a “hands free – constant monitoring” approach to all aspects of manufacturing process. RPI has invested significant resources in designing systems that support effective ingredient receipt and testing, pharmacy and pre-production processing, manufacturing, post production testing, and packaging.

The STR quality systems audit assesses the ability of a companies manufacturing process to effectively and consistently produce correctly labeled, pure, and safe product. STR analyzed the RPI Standard Operation Procedures (SOPs), staff qualifications, staff training program, and facility adequacy and cleanliness. All aspects of the manufacturing process were reviewed including receipt and authentication of ingredients, the production process, post production product analysis, product handling, packaging, storage, and record keeping. RPI, which was holds a drug manufacturing license issued by the state of California, was shown to comply with the standards mandated by the STR RQP. The RQP standards were originally created to assure safely, purity, and label claim compliance for dietary supplements marketed in a leading national retail chain.

Robinson Pharma Inc. is a minority owned, Southern California based, drug licensed, full service private label and contract manufacturer of Dietary supplements. RPI features the largest soft gel encapsulation capacity in the U.S. with 22 continuous dry encapsulation lines capable of producing over 12 billion soft gels per year. Production capabilities include tablet compression, capsule filling, enteric coating of soft gels and tablets, custom imprinting, and a range of packaging options including bottles, blister packaging boxing, and bulk product. Additional services include product development and ingredient sourcing. Robinson Pharma Inc. provides rapid turnaround on all projects and offers highly competitive pricing. Robinson Pharma Inc. maintains 400,000 square feet of production, operations, and warehousing facilities. For more information please email [email protected], Phone (714) 241-0235 or visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.